Doxorubicin-Induced Cardiomyopathy

Journal of Pediatric Oncology Nursing

Volumn 11, Issue 4, 1994, Pages 152-160

  Dunn, Joni ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ADULT; CHILD; HUMAN; IATROGENIC DISEASE; INCIDENCE; MYOCARDIAL DISEASE; NURSING; REVIEW; RISK FACTOR;

ADULT; CHILD; DOXORUBICIN; HUMAN; INCIDENCE; MYOCARDIAL DISEASES; RISK FACTORS;

EID: 0028521058     PISSN: 10434542     EISSN: 15328457     Source Type: Journal    
DOI: 10.1177/104345429401100406     Document Type: Article

References (38)

1. Lipshultz S., Colan S., Gelber R., et al: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324: 808-815, 1991
2. Steinherz L., Steinherz P., Tan C., et al: Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266: 1672-1677, 1991
3. Saltiel E., McGuire W.: Doxorubicin (Adriamycin) cardiomyopathy. Western J Med 139: 332-340, 1983
4. Halliwell B., Bomford A.: ICRF-187 and doxorubicin-induced cardiac toxicity. N Engl J Med 320: 399-400, 1989
5. Dorr R.: Chemoprotectants for cancer chemotherapy. Semin Oncol 18: 48-58, 1991
6. Inchiosa M., Smith C.: Effects of ibuprofen on doxorubicin toxicity. Res Commun Chem Pathol Pharmacol 67: 63-78, 1990
7. Doroshow J.: Doxorubicin-induced cardiac toxicity. N Engl J Med 324: 843-845, 1991
8. Steinherz L., Steinherz P.: Delayed anthracycline cardiac toxicity. Cancer Principles Practice Oncol 5: 1-15, 1991
9. Unverferth D., Magorien R., Leier C., et al: Doxorubicin cardiotoxicity. Cancer Treat Rev 2: 149-164, 1982
10. Borow K., Henderson C., Neuman A.: Assessment of left ventricular contractility in patients receiving doxorubicin. Ann Intern Med 99: 750-756, 1983
11. Steinherz L., Steinherz P.: Delayed cardiac toxicity from anthracycline therapy. Pediatrician 18: 49-52, 1991
12. Guyton A.: Textbook of Medical Physiology (ed 6). Philadelphia, PA, Saunders, 1981, pp 150-175; 274-287
13. Bristow M., Mason J., Billingham M., et al: Dose-effect and structure function relationship in doxorubicin cardiomyopathy. Am Heart J 102: 709-718, 1981
14. Goorin A., Borow K., Goldman A., et al: Congestive heart failure due to adriamycin cardiotoxicity—Its natural history in children. Cancer 47: 2810-2816, 1981
15. Steinherz L., Graham T., Hurwitz R., et al: Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the cardiology committee of the Children's Cancer Study Group. Pediatrics 89: 942-949, 1992
16. Lipshultz S.: Personal communication, Fall 1989
17. Sallon S.: Unpublished manuscript, 1989
18. Larsen R.: Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. Am J Cardiol 70: 1991
19. Gazes P.: Clinical Cardiology: A Bedside Approach. Chicago, IL, Year Book Medical, 1983
20. Walts R.: Severe and fatal anthracycline cardiotoxicity at cumulative doses below 400 mg/m2: Evidence for enhanced toxicity with multi-agent chemotherapy. Am J Hematol 36: 217-218, 1991
21. Larsen R., Jakacki R., Vetter V., et al: Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. Am J Cardiol 70: 73-77, 1992
22. Goorin A., Chauvenet A., Perez-Atayde A., et al: Initial congestive heart failure 6-10 years after doxorubicin chemotherapy for childhood cancer. J Pediatr 116: 144-147, 1990
23. Klewer S., Goldberg S., Donnerstein R., et al: Dobutamine stress echocardiography: A sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. J Am Coll Cardiol 19: 394-401, 1992
24. Weesner K., Bledsoe M., Chauvenet A., et al: Exercise echocardiography in the detection of anthracycline cardiotoxicity. Cancer 68: 435-438, 1991
25. Yeung S., Yoong C., Spink J., et al: Functional myocardial impairment in children treated with anthracyclines for cancer. Lancet 337: 816-817, 1991
26. Lipshultz S., Colan S., Sallow S., et al: Afterload reduction therapy in long-term survivors of childhood cancer treated with doxorubicin. Am Heart Assoc: 64th Scientific Session, 1991
27. Santostasi G., Kutty R., Krishna G., et al: Increased toxicity of anthracycline antibiotics induced by calcium entry blockers in cultured cardiomyocytes. Toxicol App Pharmacol 108: 140-149, 1991
28. Arico M., Pedroni E., Nespoli L., et al: Long-term survival after heart transplantation for doxorubicin-induced cardiomyopathy. Arch Dis Child 66: 985-986, 1991
29. Hitchcock-Bryan, Gelber R., Cassady R., et al: The impact of induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 14: 211-215, 1986
30. Carter M., Thompson E., Simone J.: The survivors of childhood solid tumors. Pediatr Clin North Am 38: 505-526, 1991
31. Meyer R.: Echocardiography, in Adams F, Emmanouilides G (eds): Moss' Heart Disease in Infants, Children, and Adolescents. Baltimore, MD, Williams and Wilkins, 1983, pp 58-82
32. Yamada T., Matsumari A., Tamaki N., et al: Detection of adriamycin cardiotoxicity with indium-111 labeled Actinomyosin monoclonal antibody imaging. Jpn Circ J 55: 377-383, 1991
33. Merz B., Hager T.: Diffusing adverse effects of anticancer drugs. JAMA 250: 459, 1983
34. Rajagapalon E., Politi P., Sinha, et al: Adriamycin-induced free radical formation in the perfused rat heart: Implications for cardiotoxicity. Cancer Res 48: 4766-4769, 1988
35. Speyer J., Green M., Kramer E., et al: Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. N Engl J Med 319: 745-752, 1988
36. Powis G.: Metabolism and reactions of quinoid anticancer agents. Pharmacol Ther 35: 57-62, 1987
37. Green M., Speyer J., et al: A prospective randomized trial of ICRF-187 for prevention of cumulation doxorubicin-induced cardiac toxicity in women with breast cancer. Cancer Treat Rev 17: 161-163, 1990
38. Meadows A., Krejmas N., Belasis J.: The Medical Cost of Cure: Sequelae in Survivors of Childhood Cancer. New York, NY, Raven, p 263, 1980